Profil
Mr. Kevin Lyne-Smith is Head of Global Equity Research at Credit Suisse AG.
He joined Credit Suisse Group in 2008.
Prior to this position, he was a Managing Director of Research at Julius Baer for 10 years initially responsible for brokerage research and later from establishing buy-side research function.
From 1994-1999, Mr. Lyne-Smith worked as a Finance Director for the biotechnology company Serono.
During the period 1986-1994, he held various management positions at Ford Motor Company where he worked in the UK and Germany on joint ventures, vehicle programs and strategic projects.
Finally, he started his career as a toxicologist at GlaxoSmithKline's European Research Centre where he specialized in neurological peptides.
Mr. Lyne-Smith holds an MBA from the Warwick Business School and a BSc Honours in Toxicology & Pharmacology from the University of London.
Anciens postes connus de Kevin Lyne-Smith
| Sociétés | Poste | Fin |
|---|---|---|
Credit Suisse AG (Private Banking)
Credit Suisse AG (Private Banking) Investment ManagersFinance CSPB is an active manager which performs in-house research. The firm's Investment Committee defines the investment strategy. In addition, based on the economic and financial analyses carried out by Credit Suisse Investment Research, the Investment Committee decides on the weighting of investment assets in the individual investment vehicles including money markets, bonds, equities, alternative investments, commodities and cash. The firm's Investment Committee also decides on short and medium-term trading options in a three to six-month horizon. The investment policy is monitored continuously at the Investment Committee's weekly meetings. | Directeur de la Recherche - Actions | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Credit Suisse AG (Private Banking)
Credit Suisse AG (Private Banking) Investment ManagersFinance CSPB is an active manager which performs in-house research. The firm's Investment Committee defines the investment strategy. In addition, based on the economic and financial analyses carried out by Credit Suisse Investment Research, the Investment Committee decides on the weighting of investment assets in the individual investment vehicles including money markets, bonds, equities, alternative investments, commodities and cash. The firm's Investment Committee also decides on short and medium-term trading options in a three to six-month horizon. The investment policy is monitored continuously at the Investment Committee's weekly meetings. | Finance |
















